OpenEvidence Launches Free Access Intelligence Tools for Clinicians
What happened
On November 11, 2026, OpenEvidence introduced Access Intelligence, a new set of tools built into its clinical AI platform. This suite is available for free to all clinicians and is designed to help manage patient affordability and insurance coverage after a treatment decision is made. The tools provide access to information and enrollment for over 2,500 patient-support programs, as well as features for drafting and refining prior-authorization documents. The launch aims to simplify the administrative steps clinicians face when helping patients access prescribed treatments.
Key details
- Access Intelligence launched on November 11, 2026.
- The suite is free for all clinicians using the OpenEvidence platform.
- It includes daily-updated information on more than 2,500 patient-support programs.
- Clinicians can complete enrollment for support programs directly within the platform.
- Over 500,000 prior-authorization documents had already been created on OpenEvidence before this launch.
Why it matters
Clinicians now have a single platform to handle both treatment decisions and the administrative work needed to secure patient access to care. This reduces the time and effort required to find support programs, complete paperwork, and draft insurance documents. Patients may benefit from faster and more reliable access to affordability resources and insurance approvals, potentially reducing delays in receiving recommended treatments.